PL

Pablo Lubroth

Founder of Decoding Bio

New York, New York

Overview

Pablo Lubroth is an Investor at Hummingbird Ventures in New York City, specializing in biotechnology investments across various sectors and stages, including Series B, Pre-seed, and Seed rounds. With a background in research and co-founding ventures like Decoding Bio and Hera Biotech, he has successfully invested in companies like Waypoint Bio and Enveda Biosciences, contributing to the growth of innovative biotech startups.

Work Experience

Hummingbird Ventures

Investor
2020 - Current
Leading the biotech practice Investor and/or Board Member: Amber Bio, Enveda Biosciences, Kaleidoscope, Kernal Bio, Pheiron, Serna Bio, Waypoint Bio, Automata, Basecamp Research

Decoding Bio

Co-Founder
2022
Your missing guide to breakthrough biotech

Decoding Bio mission is to translate technical developments and trends into an easy-to-read format.

decodingbio.com

Future Planet Capital

Investor
2018 - 2020
UK-based biotech incubations & spin-outs Incubated/Invested in Solasta Bio, NanoSyrinx, Pencil Biosciences, MicrofluidX

Horizon Discovery

Corporate Development Associate
2018 - 2018
BD&L and M&A of gene editing assets and companies

Welcome to SAGE® Labs, your source for unique, next-generation animal research models featuring specific gene deletions

sageresearchlabs.com

Hera Biotech

Co-Founder
2015 - 2016
Reducing peripheral side effects of CNS-acting drugs via ultrasound-sensitive nanoparticles.

University of Cambridge

Research
2015 - 2015
Researched the neurobiological roots of drug addiction and obsessive-compulsive spectrum disorders at the Belin Lab.

UCL

Research
2014 - 2014
Researched novel drug targets for diabetes.

Education

Investments

Waypoint Bio

Total funding: $15M

Enveda Biosciences

Total funding: $220M

Kaleidoscope

Total funding: $22M

NanoSyrinx

Total funding: $8M

Articles About Pablo

Relevant Websites